Cancer biotech Viracta nabs Nordic Nanovector exec as CMO
Lisa Rojkjaer, M.D., has been named Viracta’s new chief medical officer as Nordic Nanovector adds interim replacement.

Apr 10, 2020 0 27
Mar 6, 2020 0 21
Mar 25, 2020 0 18
Mar 17, 2020 0 16
Mar 13, 2020 0 15
Mar 13, 2020 0 403
Apr 6, 2020 0 155
All three biotechs are developing drugs for patients with a genetic condition called...
May 20, 2020 0 175
Eight publicly traded drugmakers, including Moderna, announced plans Monday to raise...
Mar 24, 2020 0 153
Fluid analyzing platform allows researchers to isolate and study the mechanical...
Mar 27, 2020 0 155
Credit: University of Colorado Cancer Center Most ovarian cancer starts in fallopian...
Apr 1, 2020 0 186
Credit: Jacynthe Dessureault-Rompre In many regions of the world, farming must be...
Apr 9, 2020 0 158
The development of the first high-repetition-rate laser source that produces coherent...
Apr 28, 2020 0 139
Compass Pathways has raised $80 million to prepare its psilocybin therapy for phase...